Is DOTS-plus a feasible and cost-effective strategy?
Paul Garner, Marissa Alejandria, Mary Ann Lansang
PLoS Medicine · 2006
doi:10.1371/journal.pmed.0030350 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.
Abstract licence: CC BY
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.